Amarin Corporation PLC reports results for the quarter ended December 31 - Earnings Summary

Amarin

12/03/2025 13:31

Amarin Corporation PLC AMRN.OQ reported a quarterly adjusted loss of 3 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -1 cents.  The mean expectation of three analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -7 cents to -4 cents per share.

Revenue fell 19.6% to $60.07 million from a year ago; analysts expected $35.92 million.

Amarin Corporation PLC's reported EPS for the quarter was a loss of 12 cents​.

The company reported a quarterly loss of $48.62 million.

Amarin Corporation PLC shares had fallen by 3.0% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "sell" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 2 "sell" or "strong sell."

The average consensus recommendation for the biotechnology & medical research peer group is also "sell"

Wall Street's median 12-month price target for Amarin Corporation PLC is $1.00

This summary was machine generated from LSEG data March 12 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-0.05
-0.03
Beat
Sep. 30 2024
-0.05
-0.06
Missed
Jun. 30 2024
-0.04
0.00
Beat
Mar. 31 2024
-0.03
-0.02
Beat